DE60324393D1 - Nichtinvasive messung der biosynthese- und abbaugeschwindigkeiten biologischer moleküle, die einer direkten probenahme unzugänglich oder nicht leicht zugänglich sind, durch einbau einer markierung in metabolische derivate und katabole produkte - Google Patents
Nichtinvasive messung der biosynthese- und abbaugeschwindigkeiten biologischer moleküle, die einer direkten probenahme unzugänglich oder nicht leicht zugänglich sind, durch einbau einer markierung in metabolische derivate und katabole produkteInfo
- Publication number
- DE60324393D1 DE60324393D1 DE60324393T DE60324393T DE60324393D1 DE 60324393 D1 DE60324393 D1 DE 60324393D1 DE 60324393 T DE60324393 T DE 60324393T DE 60324393 T DE60324393 T DE 60324393T DE 60324393 D1 DE60324393 D1 DE 60324393D1
- Authority
- DE
- Germany
- Prior art keywords
- accessible
- biosynthesis
- biological molecules
- products
- katabole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0493—Steroids, e.g. cholesterol, testosterone
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35600802P | 2002-02-12 | 2002-02-12 | |
PCT/US2003/004183 WO2003068919A2 (en) | 2002-02-12 | 2003-02-12 | Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60324393D1 true DE60324393D1 (de) | 2008-12-11 |
Family
ID=27734594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60324393T Expired - Lifetime DE60324393D1 (de) | 2002-02-12 | 2003-02-12 | Nichtinvasive messung der biosynthese- und abbaugeschwindigkeiten biologischer moleküle, die einer direkten probenahme unzugänglich oder nicht leicht zugänglich sind, durch einbau einer markierung in metabolische derivate und katabole produkte |
Country Status (9)
Country | Link |
---|---|
US (2) | US7449171B2 (de) |
EP (1) | EP1483399B1 (de) |
JP (1) | JP2005517904A (de) |
AT (1) | ATE412906T1 (de) |
AU (1) | AU2003217385B2 (de) |
CA (1) | CA2475924C (de) |
DE (1) | DE60324393D1 (de) |
TW (1) | TWI263677B (de) |
WO (1) | WO2003068919A2 (de) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5910403A (en) | 1997-05-15 | 1999-06-08 | The Regents Of University Of California | Methods for measuring cellular proliferation and destruction rates in vitro and in vivo |
US7001587B2 (en) * | 2001-10-24 | 2006-02-21 | The Regents Of The University Of California | Measurement of protein synthesis rates in humans and experimental systems by use of isotopically labeled water |
EP1483399B1 (de) | 2002-02-12 | 2008-10-29 | The Regents of the University of California | Nichtinvasive messung der biosynthese- und abbaugeschwindigkeiten biologischer moleküle, die einer direkten probenahme unzugänglich oder nicht leicht zugänglich sind, durch einbau einer markierung in metabolische derivate und katabole produkte |
AU2003234688A1 (en) * | 2002-04-05 | 2003-10-27 | The Regents Of The University Of California | Method for isolating and measuring proliferation of long-term label retaining cells and stem cells |
US20060094057A1 (en) | 2002-07-30 | 2006-05-04 | Maro K. Hellerstein | Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
AU2003268416A1 (en) * | 2002-09-04 | 2004-03-29 | The Regents Of The University Of California | Methods for measuring rates of replication and death of nfectious microbial agents in an infected host organism |
US7255850B2 (en) | 2002-09-13 | 2007-08-14 | The Regents Of The University Of California | Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis |
EP1545628A4 (de) * | 2002-09-16 | 2010-07-28 | Univ California | Biochemische verfahren zur messung der metabolischen fitness von geweben oder des gesamten organismus |
US20070248540A1 (en) * | 2002-09-16 | 2007-10-25 | The Regents Of The University Of California | Biochemical methods for measuring metabolic fitness of tissues or whole organisms |
EP1558293A4 (de) | 2002-11-04 | 2006-10-25 | Univ California | Deuterierte glucose- oder fetttoleranztests für die messung des stoffwechsels vonzuckern oder fettsüuren im k rper mit hohem durchsatz |
US7262020B2 (en) | 2003-07-03 | 2007-08-28 | The Regents Of The University Of California | Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
US20050202406A1 (en) * | 2003-11-25 | 2005-09-15 | The Regents Of The University Of California | Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems |
TW200538738A (en) | 2004-02-20 | 2005-12-01 | Univ California | Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity |
US20050201937A1 (en) * | 2004-03-11 | 2005-09-15 | The Regents Of The University Of California | Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients |
US20050238577A1 (en) * | 2004-03-29 | 2005-10-27 | The Regents Of The University Of California | Isolation of epithelial cells or their biochemical contents from excreta after in vivo isotopic labeling |
EP1784647A1 (de) * | 2004-08-07 | 2007-05-16 | Kinemed, Inc. | Verfahren zur messung der dynamik selbstanlagernder systeme biologischer moleküle in vivo sowie verwendungen zur entdeckung oder beurteilung von therapeutika |
WO2006107814A2 (en) * | 2005-04-06 | 2006-10-12 | Washington University In St. Louis | Methods for measuring the metabolism of neurally derived biomolecules in vivo |
JP2006292683A (ja) * | 2005-04-14 | 2006-10-26 | National Institute Of Advanced Industrial & Technology | ケラタン硫酸由来オリゴ糖の同定方法 |
US20060251576A1 (en) * | 2005-05-03 | 2006-11-09 | The Regents Of The University Of California | Methods for measuring cholesterol metabolism and transport |
TW200711660A (en) | 2005-06-10 | 2007-04-01 | Univ California | Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development |
FI20050814A0 (fi) * | 2005-08-11 | 2005-08-11 | Procollagen Oy | Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi |
WO2007035397A1 (en) * | 2005-09-15 | 2007-03-29 | The Regents Of The University Of Michigan | Method and system for measuring cartilage condition biomarkers |
EP1949085A4 (de) * | 2005-09-30 | 2010-02-17 | Kinemed Inc | Mikrotubulisynthese als biomarker |
JP5297201B2 (ja) | 2006-01-05 | 2013-09-25 | キナメッド・インコーポレイテッド | 運動ニューロン疾患の調節物質を用いる治療方法および組成物 |
GB0612669D0 (en) * | 2006-06-27 | 2006-08-09 | Univ Leeds | Biomarkers for preeclampsia |
US20090142766A1 (en) * | 2007-11-09 | 2009-06-04 | Washington University In St. Louis | Methods for measuring the metabolism of cns derived biomolecules in vivo |
JP2011523848A (ja) * | 2008-05-21 | 2011-08-25 | キネメッド, インコーポレイテッド | 運動ニューロン疾患の調節物質を用いる処置方法および組成物 |
WO2009153783A1 (en) * | 2008-06-16 | 2009-12-23 | Mor Research Applications Ltd. | Monitoring skin metabolism products for evaluating burn injury |
JP2011525194A (ja) * | 2008-06-20 | 2011-09-15 | キネメッド, インコーポレイテッド | 線維性疾患または病態を治療するための組成物 |
CN102246033A (zh) * | 2008-11-12 | 2011-11-16 | 华盛顿大学 | 生物分子的同种型的体内代谢的同时测量 |
EP2373988B1 (de) * | 2008-12-05 | 2015-02-18 | C2N Diagnostics | Verfahren zur messung von biomolekülkonzentrationen |
US9029530B2 (en) | 2009-01-02 | 2015-05-12 | Biomarin Pharmaceutical Inc. | Detection of oligosaccharides |
US8183003B2 (en) | 2009-01-02 | 2012-05-22 | Zacharon Pharmaceuticals, Inc. | Polymer end group detection |
US8232073B2 (en) | 2009-01-02 | 2012-07-31 | Zacharon Pharmaceuticals, Inc. | Quantification of non-reducing end glycan residual compounds |
US8809009B2 (en) | 2009-01-02 | 2014-08-19 | Biomarin Pharmaceutical Inc. | Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker |
US20100248380A1 (en) * | 2009-03-13 | 2010-09-30 | Arete Therapeutics, Inc. | Method and assays for quantitation of acetamide in a composition |
US20130115716A1 (en) * | 2010-05-24 | 2013-05-09 | The Washington University | Methods of determining amyloid beta turnover in blood |
US9110008B2 (en) | 2010-07-26 | 2015-08-18 | Los Gatos Research | Method for isotopic analysis of water in bodily fluids |
WO2012049560A1 (en) * | 2010-10-13 | 2012-04-19 | Council Of Scientific & Industrial Research | Biomarker for valvular heart disease |
WO2012056447A1 (en) | 2010-10-25 | 2012-05-03 | Brain Watch Ltd. | Isotopically labeled deoxy-glucose and derivatives thereof, compositions comprising them and uses thereof |
EP2657346B1 (de) | 2010-12-24 | 2017-08-23 | ARKRAY, Inc. | Verfahren für den nachweis von krebszellen |
EP2753707A4 (de) | 2011-09-08 | 2015-03-04 | Univ California | Metabolische flussmessung, abbildung und mikroskopie |
EP2786137A4 (de) * | 2011-12-02 | 2015-06-17 | C2N Diagnostics | Verfahren zur messung von biomolekülkonzentrationen |
JP6294233B2 (ja) | 2011-12-07 | 2018-03-14 | グラクソスミスクライン エルエルシー | 全身骨格筋量の定量方法 |
AU2012359020B2 (en) * | 2011-12-19 | 2017-04-13 | The Washington University | Methods for diagnosing Alzheimer's disease |
US20150140672A1 (en) * | 2011-12-19 | 2015-05-21 | Washington University | Methods for detecting amyloid beta amyloidosis |
JP5845236B2 (ja) * | 2012-11-29 | 2016-01-20 | 株式会社ニッピ | コラーゲンの分析方法、および安定同位体標識コラーゲンの製造方法 |
US9134319B2 (en) | 2013-03-15 | 2015-09-15 | The Regents Of The University Of California | Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo |
ES2705687T3 (es) * | 2013-11-05 | 2019-03-26 | Tepha Inc | Composiciones y dispositivos de poli-4-hidroxibutirato |
US9187576B2 (en) * | 2013-11-25 | 2015-11-17 | Deuteria Biomaterials, Llc | Deuterium-enriched hyaluronan |
WO2015171907A1 (en) * | 2014-05-08 | 2015-11-12 | Jasper John P | Isotopic identification and tracing of biologic products |
US10830775B2 (en) | 2014-09-30 | 2020-11-10 | Washington University | Tau kinetic measurements |
CN110573478B (zh) * | 2017-04-20 | 2023-02-28 | 梅塔博隆股份有限公司 | 检测和量化有机酸代谢产物的质谱测定方法 |
US11085935B2 (en) | 2018-05-03 | 2021-08-10 | Washington University | Methods of treating based on site-specific tau phosphorylation |
CN108663449A (zh) * | 2018-05-15 | 2018-10-16 | 安徽相王医疗健康股份有限公司 | 一种煤工尘肺患者血清中蛋白参数分析方法 |
US11754478B2 (en) | 2018-08-16 | 2023-09-12 | Abb Schweiz Ag | Rapid equilibrator for water isotope analysis |
CN111007170B (zh) * | 2019-12-13 | 2021-06-29 | 中国农业科学院农产品加工研究所 | 骨肽干预治疗骨质疏松中的生物标志物、筛选方法及用途 |
Family Cites Families (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4065552A (en) * | 1975-05-05 | 1977-12-27 | Giovanni Giacomo Costa | Method of detecting malignant neoplasms |
US4332784A (en) * | 1979-02-06 | 1982-06-01 | The Radiochemical Centre Limited | Dual isotope assays |
SU968036A1 (ru) | 1980-03-10 | 1982-10-23 | Научно-исследовательский институт медицинской радиологии АМН СССР | Способ получени меченого белка |
US5317098A (en) * | 1986-03-17 | 1994-05-31 | Hiroaki Shizuya | Non-radioisotope tagging of fragments |
EP0248924B1 (de) * | 1986-06-09 | 1989-11-23 | Bruker Analytische Messtechnik GmbH | Verfahren zur Bestimmung des Metabolismus von organischen Materialien in lebendem Gewebe und Kernspinspektrometer für die Durchführung des Verfahrens |
US4940658A (en) * | 1986-11-20 | 1990-07-10 | University Patents, Inc. | Assay for sulfhydryl amino acids and methods for detecting and distinguishing cobalamin and folic acid deficency |
US5167948A (en) * | 1987-08-07 | 1992-12-01 | Mallinckrodt Medical, Inc. | Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound |
US5042488A (en) * | 1987-09-29 | 1991-08-27 | The Washington University | Methods employing deuterium for obtaining direct, observable deuterium magnetic resonance images in vivo and in situ |
US6004781A (en) | 1988-01-22 | 1999-12-21 | The General Hospital Corporation | Nucleic acid encoding Ig-CD4 fusion proteins |
EP0467885A4 (en) | 1989-03-20 | 1993-03-31 | Anticancer Inc. | Native-state method and system for determining viability and proliferative capacity of tissues -i(in vitro) |
GB2229718B (en) | 1989-03-22 | 1993-01-06 | Inst Molekularnoi Genetik | Method for preparing hydrogen-isotape labelled biologically active organic compounds |
US5217903A (en) * | 1990-05-15 | 1993-06-08 | Trustees Of Boston University | Measuring connective tissue breakdown products in body fluids |
CA2027714C (en) * | 1990-07-13 | 2003-01-28 | Kenneth W. Turtletaub | Method of measurement in biological systems |
US5209919A (en) * | 1990-07-13 | 1993-05-11 | Regents Of The University Of California | Method of measurement in biological systems |
US5597548A (en) * | 1990-07-18 | 1997-01-28 | Board Of Regents, The University Of Texas System | 13 C Isotopomer analyses in intact tissue using (13 C) homonuclear decoupling |
HU208084B (en) | 1991-10-31 | 1993-08-30 | Hyd Kutato Fejlesztoe Kft | Process for producing compositions suitable for curing tumorous diseases |
US5394236A (en) * | 1992-02-03 | 1995-02-28 | Rutgers, The State University | Methods and apparatus for isotopic analysis |
CA2117749A1 (en) | 1992-04-08 | 1993-10-28 | Paavo Kai Johannes Kinnunen | Composition for therapeutic or diagnostic use, process for its preparation and its use |
US5338686A (en) * | 1992-04-29 | 1994-08-16 | Hellerstein Marc K | Method for measuring in vivo synthesis of biopolymers |
JP2960832B2 (ja) | 1992-05-08 | 1999-10-12 | ペルマテック テクノロジー アクチェンゲゼルシャフト | エストラジオールの投与システム |
US5366885A (en) | 1992-06-09 | 1994-11-22 | Barranco Iii Sam C | Method and kit for testing tumors for drug sensitivity |
US5432058A (en) | 1992-09-30 | 1995-07-11 | Lange, Iii; Louis G. | Method for measuring human cholesterol absorption using metabolically stable isotopes |
US5345662A (en) * | 1993-03-08 | 1994-09-13 | Langis Lambert | Apparatus for inserting a spline into a frame groove |
US5506147A (en) * | 1993-04-15 | 1996-04-09 | Kolhouse; J. Fred | Non-invasive evaluation of maldigestion and malaborption |
DK0650396T3 (da) | 1993-05-17 | 1998-09-14 | Amersham Int Plc | Udstyr og fremgangsmåde til måling af celluære biokemiske processer. |
US5439803A (en) * | 1993-08-13 | 1995-08-08 | The Regents Of The University Of Michigan | Isotope and assay for glycolysis and the pentose phosphate pathway |
CA2176005A1 (en) | 1993-11-08 | 1995-05-18 | Trevor G. Redgrave | Labelled diagnostic compositions and methods of their use |
ES2201190T3 (es) | 1995-08-08 | 2004-03-16 | Otsuka Pharmaceutical Co., Ltd. | Composiciones diagnosticas y su uso para la deteccion de anormalidades del sistema nervioso central. |
US5922554A (en) | 1995-10-30 | 1999-07-13 | The Regents Of The University Of California | Inhibition of cellular uptake of cholesterol |
US5916538A (en) | 1996-08-27 | 1999-06-29 | Tokyo Gas Company Limited | Diagnostic agent for diabetes |
JP2002505737A (ja) | 1997-02-14 | 2002-02-19 | ジョージワシントン大学 | Dna合成速度測定のための分析 |
JP2002514302A (ja) | 1997-03-14 | 2002-05-14 | ジョージワシントン大学 医学、健康科学部 | フッ素ベースの化学反応を追跡しながら連続的に同位体比を監視する装置 |
US5910403A (en) * | 1997-05-15 | 1999-06-08 | The Regents Of University Of California | Methods for measuring cellular proliferation and destruction rates in vitro and in vivo |
US5961470A (en) * | 1997-07-09 | 1999-10-05 | Wagner; David A. | Breath test for assessing hepatic function |
US6329208B1 (en) * | 1997-07-16 | 2001-12-11 | Board Of Regents, The University Of Texas System | Methods for determining gluconeogenesis, anapleurosis and pyruvate recycling |
CA2249173C (en) * | 1997-10-06 | 2008-12-16 | Tokyo Gas Co., Ltd. | Diagnostic agent for liver function |
US5924995A (en) | 1997-11-10 | 1999-07-20 | Meretek Diagnostics | Non-invasive method for the functional assessment of infants and children with an inherited metabolic disorder |
US6461870B2 (en) * | 1998-05-06 | 2002-10-08 | Isotechnika Inc. | 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control |
DE1075286T1 (de) * | 1998-05-06 | 2002-05-23 | Isotechnika,Inc. | 13C-Glukose-Atemtest zur Diagnose von Diabetes-Indikationen und Überwachung der glykämischen Kontrolle |
US6284219B1 (en) | 1998-06-30 | 2001-09-04 | Phenome Sciences Inc. | In vivo determination of metabolic function for use in therapy management |
US6625547B1 (en) * | 1998-08-05 | 2003-09-23 | Washington State University Research Foundation | Relative rates of cytochrome p450 metabolism |
DE69912444T3 (de) | 1998-08-25 | 2010-05-06 | University Of Washington, Seattle | Schnelle quantitative analyse von proteinen oder proteinfunktionen in komplexen gemischen |
DE19839491A1 (de) * | 1998-08-29 | 2000-03-02 | Hermann Heumann | Verfahren zur Markierung von Biopolymeren mit Isotopen |
AU5585599A (en) * | 1998-08-31 | 2000-03-21 | University Of Washington | Stable isotope metabolic labeling for analysis of biopolymers |
US6693186B2 (en) | 1998-09-01 | 2004-02-17 | Antex Biologics Inc | Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
US6887712B1 (en) * | 1998-11-09 | 2005-05-03 | Atherogenics, Inc. | Methods and compositions to lower plasma cholesterol levels |
EP2293056A3 (de) | 1999-04-20 | 2011-06-29 | Target Discovery, Inc. | Verfahren zur Analyse eines Stoffwechselweges |
US20030119069A1 (en) | 1999-04-20 | 2003-06-26 | Target Discovery, Inc. | Labeling of protein samples |
US6764817B1 (en) | 1999-04-20 | 2004-07-20 | Target Discovery, Inc. | Methods for conducting metabolic analyses |
US6391649B1 (en) | 1999-05-04 | 2002-05-21 | The Rockefeller University | Method for the comparative quantitative analysis of proteins and other biological material by isotopic labeling and mass spectroscopy |
US7057168B2 (en) | 1999-07-21 | 2006-06-06 | Sionex Corporation | Systems for differential ion mobility analysis |
US6902712B2 (en) * | 1999-10-12 | 2005-06-07 | General Hospital Supply Corporation | Absorbent liner for sterilization process and method of sterilizing surgical instruments |
US6653090B1 (en) * | 1999-11-05 | 2003-11-25 | University Of Alberta | Methods for measuring the metabolism of and screening for drugs in isolated hearts |
JP2001211782A (ja) | 2000-02-02 | 2001-08-07 | Masa Yamamoto | tob遺伝子欠損ノックアウト非ヒト哺乳動物 |
CA2405722A1 (en) | 2000-04-13 | 2001-11-08 | Thermo Finnigan Llc | Proteomic analysis by parallel mass spectrometry |
CA2402871C (en) * | 2000-05-05 | 2011-08-23 | Purdue Research Foundation | Affinity selected signature peptides for protein identification and quantification |
WO2001087352A1 (en) | 2000-05-18 | 2001-11-22 | Metabolic Solutions, Inc. | Reverse isotope dilution assay and lactose intolerance assay |
US6680203B2 (en) | 2000-07-10 | 2004-01-20 | Esperion Therapeutics, Inc. | Fourier transform mass spectrometry of complex biological samples |
US7048907B2 (en) | 2001-02-05 | 2006-05-23 | Biophysics Assay Laboratory, Inc. | Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products |
GB0106923D0 (en) * | 2001-03-20 | 2001-05-09 | Univ Dundee | Liver function test |
US7256047B2 (en) * | 2001-05-01 | 2007-08-14 | Board Of Regents, The University Of Texas System | Measurement of gluconeogenesis and intermediary metabolism using stable isotopes |
US20040253647A1 (en) * | 2001-06-26 | 2004-12-16 | Mathews Paul M. | Cell-based high-throughput screening methods |
US6835927B2 (en) | 2001-10-15 | 2004-12-28 | Surromed, Inc. | Mass spectrometric quantification of chemical mixture components |
US7001587B2 (en) * | 2001-10-24 | 2006-02-21 | The Regents Of The University Of California | Measurement of protein synthesis rates in humans and experimental systems by use of isotopically labeled water |
CA2465297C (en) | 2001-12-08 | 2011-02-15 | Micromass Uk Limited | Method of mass spectrometry |
US7635841B2 (en) | 2001-12-12 | 2009-12-22 | Micromass Uk Limited | Method of mass spectrometry |
EP1483399B1 (de) | 2002-02-12 | 2008-10-29 | The Regents of the University of California | Nichtinvasive messung der biosynthese- und abbaugeschwindigkeiten biologischer moleküle, die einer direkten probenahme unzugänglich oder nicht leicht zugänglich sind, durch einbau einer markierung in metabolische derivate und katabole produkte |
US20030180710A1 (en) * | 2002-03-22 | 2003-09-25 | Lee Wai-Nang Paul | Method of enhancing the efficiency of a pharmaceutical business |
US20030180800A1 (en) * | 2002-03-22 | 2003-09-25 | Lee Wai-Nang Paul | Stable isotope based dynamic metabolic profiling of living organisms for characterization of metabolic diseases, drug testing and drug development |
US20050281745A1 (en) | 2002-03-22 | 2005-12-22 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Stable isotope based dynamic metabolic profiling of living organisms for characterization of metabolic diseases, drug testing and drug development |
US20060100903A1 (en) | 2002-03-22 | 2006-05-11 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Method of enhancing the efficiency of a pharmaceutical business |
AU2003234688A1 (en) * | 2002-04-05 | 2003-10-27 | The Regents Of The University Of California | Method for isolating and measuring proliferation of long-term label retaining cells and stem cells |
US20030211036A1 (en) | 2002-05-07 | 2003-11-13 | Hadassa Degani | Method and apparatus for monitoring and quantitatively evaluating tumor perfusion |
US20030228059A1 (en) * | 2002-06-06 | 2003-12-11 | Atul Khanduri | Data collator for a plurality of asynchronous/synchronous data generation entities |
US7510880B2 (en) | 2002-06-26 | 2009-03-31 | Gross Richard W | Multidimensional mass spectrometry of serum and cellular lipids directly from biologic extracts |
US20060094057A1 (en) | 2002-07-30 | 2006-05-04 | Maro K. Hellerstein | Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
AU2003265448A1 (en) | 2002-08-16 | 2004-03-03 | The Regents Of The University Of California | Dynamic hepatic recycling glucose tolerance test |
AU2003268416A1 (en) | 2002-09-04 | 2004-03-29 | The Regents Of The University Of California | Methods for measuring rates of replication and death of nfectious microbial agents in an infected host organism |
US7255850B2 (en) * | 2002-09-13 | 2007-08-14 | The Regents Of The University Of California | Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis |
US20070248540A1 (en) | 2002-09-16 | 2007-10-25 | The Regents Of The University Of California | Biochemical methods for measuring metabolic fitness of tissues or whole organisms |
EP1545628A4 (de) * | 2002-09-16 | 2010-07-28 | Univ California | Biochemische verfahren zur messung der metabolischen fitness von geweben oder des gesamten organismus |
SG158737A1 (en) | 2002-10-29 | 2010-02-26 | Target Discovery Inc | Method for increasing ionization efficiency in mass spectroscopy |
EP1558293A4 (de) * | 2002-11-04 | 2006-10-25 | Univ California | Deuterierte glucose- oder fetttoleranztests für die messung des stoffwechsels vonzuckern oder fettsüuren im k rper mit hohem durchsatz |
US20040121305A1 (en) | 2002-12-18 | 2004-06-24 | Wiegand Roger Charles | Generation of efficacy, toxicity and disease signatures and methods of use thereof |
WO2004089972A2 (en) | 2003-04-02 | 2004-10-21 | Merck & Co., Inc. | Mass spectrometry data analysis techniques |
US20050014181A1 (en) | 2003-06-18 | 2005-01-20 | Galis Zorina S. | Methods and compositions for the assessment of polymer assembly |
EP1644856A2 (de) | 2003-06-30 | 2006-04-12 | Ajinomoto Co., Inc. | Analyseverfahren für den intrazellulären metabolischen fluss durch verwendung eines mit isotop gekennzeichneten substrats |
US7262020B2 (en) * | 2003-07-03 | 2007-08-28 | The Regents Of The University Of California | Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
US20050202406A1 (en) * | 2003-11-25 | 2005-09-15 | The Regents Of The University Of California | Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems |
US8510054B2 (en) | 2004-02-05 | 2013-08-13 | Ajinomoto Co., Inc. | Intracellular metabolic flux analysis method using substrate labeled with isotope |
TW200538738A (en) * | 2004-02-20 | 2005-12-01 | Univ California | Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity |
US20050201937A1 (en) * | 2004-03-11 | 2005-09-15 | The Regents Of The University Of California | Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients |
US20050238577A1 (en) * | 2004-03-29 | 2005-10-27 | The Regents Of The University Of California | Isolation of epithelial cells or their biochemical contents from excreta after in vivo isotopic labeling |
WO2005098024A1 (en) | 2004-03-30 | 2005-10-20 | Kinemed, Inc. | In vivo measurement of the relative fluxes through ribonucleotide reductase vs. deoxyribonucleoside pathways using isotopes |
JP4654592B2 (ja) | 2004-04-02 | 2011-03-23 | 味の素株式会社 | 代謝フラックスの決定方法 |
EP1824516A4 (de) | 2004-10-29 | 2008-11-05 | Target Discovery Inc | Glycan-analyse mit deuterierter glucose |
US20060251576A1 (en) | 2005-05-03 | 2006-11-09 | The Regents Of The University Of California | Methods for measuring cholesterol metabolism and transport |
TW200711660A (en) | 2005-06-10 | 2007-04-01 | Univ California | Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development |
-
2003
- 2003-02-12 EP EP03713429A patent/EP1483399B1/de not_active Expired - Lifetime
- 2003-02-12 JP JP2003568034A patent/JP2005517904A/ja active Pending
- 2003-02-12 TW TW092102867A patent/TWI263677B/zh active
- 2003-02-12 CA CA2475924A patent/CA2475924C/en not_active Expired - Lifetime
- 2003-02-12 DE DE60324393T patent/DE60324393D1/de not_active Expired - Lifetime
- 2003-02-12 US US10/366,125 patent/US7449171B2/en active Active
- 2003-02-12 WO PCT/US2003/004183 patent/WO2003068919A2/en active Application Filing
- 2003-02-12 AU AU2003217385A patent/AU2003217385B2/en not_active Ceased
- 2003-02-12 AT AT03713429T patent/ATE412906T1/de not_active IP Right Cessation
-
2008
- 2008-07-15 US US12/173,784 patent/US8084016B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2003217385B2 (en) | 2008-09-11 |
JP2005517904A (ja) | 2005-06-16 |
US7449171B2 (en) | 2008-11-11 |
EP1483399B1 (de) | 2008-10-29 |
CA2475924C (en) | 2016-03-29 |
EP1483399A2 (de) | 2004-12-08 |
US8084016B2 (en) | 2011-12-27 |
US20090041661A1 (en) | 2009-02-12 |
AU2003217385A1 (en) | 2003-09-04 |
US20030228259A1 (en) | 2003-12-11 |
EP1483399A4 (de) | 2006-07-19 |
WO2003068919A2 (en) | 2003-08-21 |
ATE412906T1 (de) | 2008-11-15 |
CA2475924A1 (en) | 2003-08-21 |
WO2003068919A3 (en) | 2004-08-19 |
TW200303217A (en) | 2003-09-01 |
TWI263677B (en) | 2006-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60324393D1 (de) | Nichtinvasive messung der biosynthese- und abbaugeschwindigkeiten biologischer moleküle, die einer direkten probenahme unzugänglich oder nicht leicht zugänglich sind, durch einbau einer markierung in metabolische derivate und katabole produkte | |
KR100711046B1 (ko) | 대장암에 대한 마커로서의 니코틴아미드n―메틸트랜스퍼라아제의 용도 | |
FR2862698B1 (fr) | Mesures d'induction avec effets de trou de sonde reduits | |
WO2008063413A3 (en) | Gene expression profiling for identification, monitoring, and treatment of lung cancer | |
WO2008017428A3 (de) | Vorrichtung zur individuellen therapieplanung und positionsgenauen modifikation eines optischen elements | |
DE60315415D1 (de) | Biosensor, magnetisches molekül messverfahren und messobjekt messverfahren | |
BRPI0619876B8 (pt) | sistema de medição, sistema para determinar o balanço calórico de um indivíduo e método de estimar um valor obtido relacionado com um indivíduo | |
TW200730129A (en) | Method and apparatus for point of care osmolarity testing | |
DE602004026239D1 (de) | Vorrichtung zur Messung der Herzfrequenz und deren Fertigungs- sowie Messverfahren | |
DE602004020281D1 (de) | Vorrichtung zur Messung des extrazellulären Potenzials | |
WO2008063414A3 (en) | Gene expression profiling for identification, monitoring, and treatment of colorectal cancer | |
WO2010006048A3 (en) | Gene expression profiling for predicting the survivability of prostate cancer subjects | |
WO2007115321A3 (en) | Visual, continuous and simultaneous measurement of solution ammonia and hydrogen ion concentration | |
WO2008069881A3 (en) | Gene expression profiling for identification, monitoring and treatment of melanoma | |
HK1133295A1 (en) | Use of protein s100a12 as a marker for colorectal cancer s100a12 | |
WO2006113477A3 (en) | Use of phosphonazo iii for the measurement of calcium, magnesium and sodium in analytical samples | |
Hasan et al. | 24. Semantic networks: the description of linguistic meaning in SFL | |
DE602004031578D1 (de) | Detektor zur Messung der Dicke eines Artikels | |
DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome | |
ATE449332T1 (de) | Alterungsbiomarker | |
DE60137748D1 (de) | Analysesystem zur Feststellung der Stickstoffkonzentration mit hoher Genauigkeit | |
FR2866112B1 (fr) | Sonde de jaugeage de liquide | |
WO2004019018A3 (en) | Method of measuring nonlinearity spatial profiles of samples and temporal profiles of optical pulses | |
ATE534037T1 (de) | Verwendung des proteins asc als marker für brustkrebs | |
DE60303994D1 (de) | Vorrichtung zur Messung der Pulswelle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |